CO2022008102A2 - Proceso e intermediarios para la producción de fórmula (i) - Google Patents
Proceso e intermediarios para la producción de fórmula (i)Info
- Publication number
- CO2022008102A2 CO2022008102A2 CONC2022/0008102A CO2022008102A CO2022008102A2 CO 2022008102 A2 CO2022008102 A2 CO 2022008102A2 CO 2022008102 A CO2022008102 A CO 2022008102A CO 2022008102 A2 CO2022008102 A2 CO 2022008102A2
- Authority
- CO
- Colombia
- Prior art keywords
- intermediates
- formula
- production
- compound
- making
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un proceso e intermediarios para hacer el compuesto de Fórmula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962943851P | 2019-12-05 | 2019-12-05 | |
PCT/EP2020/084580 WO2021110893A1 (en) | 2019-12-05 | 2020-12-04 | Process and intermediates for the production of formula (i) |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2022008102A2 true CO2022008102A2 (es) | 2022-07-08 |
Family
ID=73748050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0008102A CO2022008102A2 (es) | 2019-12-05 | 2022-06-07 | Proceso e intermediarios para la producción de fórmula (i) |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230046093A1 (es) |
EP (1) | EP4069687B1 (es) |
JP (1) | JP2023505771A (es) |
KR (1) | KR20220112764A (es) |
CN (1) | CN114746410A (es) |
AR (1) | AR120685A1 (es) |
AU (1) | AU2020397222B2 (es) |
CA (1) | CA3157504A1 (es) |
CO (1) | CO2022008102A2 (es) |
IL (1) | IL293382A (es) |
MX (1) | MX2022006856A (es) |
TW (1) | TW202134242A (es) |
WO (1) | WO2021110893A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122020014933B8 (pt) * | 2014-04-09 | 2022-12-13 | Genentech Inc | Compostos, composições farmacêuticas, benzenossulfonatos, forma a de ácido p-toluenossulfônico, forma b de ácido p-toluenssulfônico, forma i do ácido naftalenodissulfônico e forma ii do ácido naftalendissulfônico |
UY36629A (es) * | 2015-04-17 | 2016-11-30 | Abbvie Inc | Indazolonas como moduladores de la señalización de tnf |
BR112018008397B1 (pt) * | 2015-11-09 | 2023-12-12 | Astrazeneca Ab | Composto, sal farmacêuticamente aceitável e formas cristalinas |
ES2789756T3 (es) * | 2015-12-23 | 2020-10-26 | Merck Sharp & Dohme | Moduladores alostéricos de 6,7-dihidro-5H-pirrolo[3,4-b]piridin-5-ona del receptor de acetilcolina muscarínico M4 |
-
2020
- 2020-12-04 WO PCT/EP2020/084580 patent/WO2021110893A1/en unknown
- 2020-12-04 IL IL293382A patent/IL293382A/en unknown
- 2020-12-04 MX MX2022006856A patent/MX2022006856A/es unknown
- 2020-12-04 EP EP20820820.7A patent/EP4069687B1/en active Active
- 2020-12-04 TW TW109142775A patent/TW202134242A/zh unknown
- 2020-12-04 JP JP2022533631A patent/JP2023505771A/ja not_active Withdrawn
- 2020-12-04 AU AU2020397222A patent/AU2020397222B2/en active Active
- 2020-12-04 US US17/782,661 patent/US20230046093A1/en active Pending
- 2020-12-04 CA CA3157504A patent/CA3157504A1/en active Pending
- 2020-12-04 KR KR1020227018235A patent/KR20220112764A/ko unknown
- 2020-12-04 AR ARP200103398A patent/AR120685A1/es unknown
- 2020-12-04 CN CN202080082518.8A patent/CN114746410A/zh active Pending
-
2022
- 2022-06-07 CO CONC2022/0008102A patent/CO2022008102A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP4069687B1 (en) | 2024-01-31 |
TW202134242A (zh) | 2021-09-16 |
AU2020397222B2 (en) | 2023-07-06 |
MX2022006856A (es) | 2022-07-11 |
AU2020397222A1 (en) | 2022-04-28 |
JP2023505771A (ja) | 2023-02-13 |
CA3157504A1 (en) | 2021-06-10 |
WO2021110893A1 (en) | 2021-06-10 |
KR20220112764A (ko) | 2022-08-11 |
EP4069687A1 (en) | 2022-10-12 |
AR120685A1 (es) | 2022-03-09 |
IL293382A (en) | 2022-07-01 |
CN114746410A (zh) | 2022-07-12 |
US20230046093A1 (en) | 2023-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR120921A2 (es) | Herbicidas derivados de compuestos bicíclicos sustituidos con arilo | |
CL2019003154A1 (es) | Proceso de preparación de un compuesto intermediario de fórmula (vi) para la preparación de compuestos de cannabidiol. (divisional solicitud 201800079) | |
CO2022002637A2 (es) | Proceso de fabricación de moduladores de cftr | |
PH12021500013A1 (en) | New heterocyclic compounds as monoacylgylcerol lipase inhibitors | |
AR111304A1 (es) | Métodos para sintetizar un inhibidor de mcl-1 | |
EA201991241A1 (ru) | Способ получения метоксиметилпиридин дикарбоксилата | |
MX2020004313A (es) | Un metodo para la fabricacion de una lamina de acero galvanizado. | |
MX2021003070A (es) | Un proceso de fabricación de compuestos heterocíclicos de 2-nitroimino. | |
ZA202101487B (en) | Novel compounds | |
BR112019020338A8 (pt) | Composição para produção de tagatose, e, método de produção de tagatose | |
MX2020003921A (es) | Proceso para producir compuestos de tipo piridazinona herbicidas. | |
CO2022009068A2 (es) | Composición para la inhibición de la producción de hmf que comprende disacárido de alulosa | |
SA520412408B1 (ar) | عملية تحضير مركبات ثنائي أريل أوكسي بنزو ديازول غير متجانسة مزدوجة الاستبدال | |
CO2022000748A2 (es) | Compuesto de pirazolopirimidina, método de preparación para el mismo y sus aplicaciones | |
MX2022002017A (es) | Metodo para producir derivado de heterociclideno acetamida. | |
MX2019009242A (es) | Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-c iclopropanos. | |
MX2019004024A (es) | Metodo para preparar acetofenonas sustituidas con ciclopropilo. | |
CL2023001760A1 (es) | Proceso | |
EA202192840A1 (ru) | Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты | |
MX2021012754A (es) | Proceso para la produccion de acido metanosulfonico anhidro a partir de metano y so3. | |
CO2022008102A2 (es) | Proceso e intermediarios para la producción de fórmula (i) | |
EA202092707A1 (ru) | Огнеупор, шихта для его получения, способ его получения, а также применение такого огнеупора | |
CL2021000663A1 (es) | Proceso para la producción de gas de síntesis. | |
CL2021000902A1 (es) | Método para la fabricación de gemas sintéticas. | |
MX2022003879A (es) | Proceso para elaborar acidos alcansulfonicos. |